Contraindications metoprolol
Pro Research Analysisby 
Searched over 200M research papers for "contraindications metoprolol"
Contraindications of Metoprolol: A Comprehensive Overview
Introduction to Metoprolol
Metoprolol is a beta-1 selective beta-blocker widely used in the treatment of various cardiovascular conditions, including hypertension, angina pectoris, and myocardial infarction. Despite its efficacy, certain contraindications must be considered to ensure patient safety and optimal therapeutic outcomes.
Peripheral Vascular Disease (PVD)
Historically, beta-blockers were considered relatively contraindicated in patients with peripheral vascular disease (PVD). However, recent studies have shown that metoprolol, a beta-1 selective beta-blocker, can be safely administered to patients with intermittent claudication, a type of PVD. In a study involving hypertensive patients with PVD, metoprolol significantly reduced blood pressure and increased pain-free walking distance without causing significant side effects, suggesting it is not contraindicated in these patients.
Acute Myocardial Infarction (AMI)
In the context of acute myocardial infarction (AMI), metoprolol is generally contraindicated in patients with certain conditions. These include those already on beta-blockers or calcium-channel blockers, those with a heart rate of 65 beats per minute or less, and those with systolic blood pressure of 105 mm Hg or less. These contraindications are crucial to avoid exacerbating the patient's condition during the acute phase of AMI.
Chronic Obstructive Pulmonary Disease (COPD)
The use of metoprolol in patients with chronic obstructive pulmonary disease (COPD) is controversial. A randomized trial found that metoprolol did not significantly delay the time to the first exacerbation of COPD and was associated with a higher risk of hospitalization due to exacerbations. Therefore, metoprolol should be used cautiously in COPD patients, particularly those without a clear indication for beta-blocker therapy.
Post-Coronary Artery Bypass Grafting (CABG)
In patients who have undergone coronary artery bypass grafting (CABG), traditional contraindications to beta-blockers, such as severe bradycardia and hypotension, must be considered. A study evaluating the long-term use of metoprolol post-CABG found no significant reduction in death or cardiac events, highlighting the importance of adhering to contraindications to avoid adverse outcomes.
Stable Angina Pectoris
For patients with stable angina pectoris, metoprolol is generally well-tolerated. However, contraindications such as recent myocardial infarction (within the past three years) and other conditions that preclude beta-blocker use must be observed. In a long-term study, metoprolol showed similar efficacy to verapamil in reducing cardiovascular events and improving quality of life, with no significant difference in adverse effects .
General Considerations and Side Effects
Metoprolol is contraindicated in patients with severe bradycardia, significant hypotension, and certain types of heart block. Common side effects include fatigue, dizziness, and headache, which are usually mild but can be clinically significant, especially in long-term therapy .
Conclusion
While metoprolol is an effective beta-blocker for various cardiovascular conditions, it is essential to consider specific contraindications to ensure patient safety. These include conditions such as severe bradycardia, hypotension, certain heart blocks, and caution in patients with COPD. Adhering to these contraindications can help optimize therapeutic outcomes and minimize adverse effects.
Sources and full results
Most relevant research papers on this topic